Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection
Anna Zychlinsky Scharff, … , Darragh Duffy, Molly A. Ingersoll
Anna Zychlinsky Scharff, … , Darragh Duffy, Molly A. Ingersoll
Published May 30, 2019
Citation Information: JCI Insight. 2019;4(13):e122998. https://doi.org/10.1172/jci.insight.122998.
View: Text | PDF
Research Article Immunology Infectious disease

Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection

  • Text
  • PDF
Abstract

Sex-based differences influence incidence and outcome of infectious disease. Women have a significantly greater incidence of urinary tract infection (UTI) than men, yet, conversely, male UTI is more persistent, with greater associated morbidity. Mechanisms underlying these sex-based differences are unknown, in part due to a lack of experimental models. We optimized a model to transurethrally infect male mice and directly compared UTI in both sexes. Although both sexes were initially equally colonized by uropathogenic E. coli, only male and testosterone-treated female mice remained chronically infected for up to 4 weeks. Female mice had more robust innate responses, including higher IL-17 expression, and increased γδ T cells and group 3 innate lymphoid cells in the bladder following infection. Accordingly, neutralizing IL-17 abolished resolution in female mice, identifying a cytokine pathway necessary for bacterial clearance. Our findings support the concept that sex-based responses to UTI contribute to impaired innate immunity in males and provide a rationale for non–antibiotic-based immune targeting to improve the response to UTI.

Authors

Anna Zychlinsky Scharff, Matthieu Rousseau, Livia Lacerda Mariano, Tracy Canton, Camila Rosat Consiglio, Matthew L. Albert, Magnus Fontes, Darragh Duffy, Molly A. Ingersoll

×

Figure 4

Immune cell populations contain more bacteria in female mice.

Options: View larger image (or click on image) Download as PowerPoint
Immune cell populations contain more bacteria in female mice.
Female and...
Female and male C57BL/6J mice were infected with 1 × 107 CFU UPEC strain UTI89-RFP-kanR and bladders analyzed by flow cytometry. Supplemental Figure 2 depicts gating strategies. (A and B) tSNE plots show total CD45+ immune cell populations at 24 hours PI from (A) a concatenated sample of 4 female and 4 male mice and (B) the same plot with conventionally gated populations overlaid. (C) UPEC+ cells from female (left) or male (right) bladders are shown using the same tSNE parameters in A and B. (D and E) Graphs show (D) the total number of specified immune cell populations containing UPEC and (E) the percentage of UPEC+ cells within the specified immune cell populations. Data are pooled from 2–4 experiments, n = 4–5 mice per experiment. Each dot is 1 mouse, red dots depict female mice and blue dots are male mice, and lines are medians. *P < 0.05, **P < 0.01, ****P < 0.0001, Mann-Whitney test. Analyses in this figure were corrected for multiple testing by the Holm–Bonferroni method; all P < 0.05 had q < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts